Format

Send to

Choose Destination
See comment in PubMed Commons below
Heart Rhythm. 2014 Jul;11(7):1131-8. doi: 10.1016/j.hrthm.2014.03.055. Epub 2014 Mar 29.

Renal denervation for improving outcomes of catheter ablation in patients with atrial fibrillation and hypertension: early experience.

Author information

1
State Research Institute of Circulation Pathology, Novosibirsk, Russia. Electronic address: E.Pokushalov@gmail.com.
2
State Research Institute of Circulation Pathology, Novosibirsk, Russia.
3
Department of Cardiology, Athens Euroclinic, Athens, Greece.
4
The Valley Health System, New York, New York, and Ridgewood, New Jersey.

Abstract

BACKGROUND:

The potential role of renal denervation (RD) in patients with AF and less severe hypertension is unknown.

OBJECTIVE:

The purpose of this study was to assess the potential role of RD as an adjunct to pulmonary vein isolation (PVI) in patients with atrial fibrillation (AF) and moderate resistant or severe resistant hypertension.

METHODS:

The data for this study were obtained from 2 different prospective randomized studies, analyzed by meta-analysis. Patients with paroxysmal AF or persistent AF and moderate resistant hypertension (office blood pressure BP ≥140/90 mm Hg and <160/100 mm Hg; first study; n = 48) or severe resistant hypertension (≥160/100 mm Hg; second study; n = 38) were randomized to PVI or PVI with RD.

RESULTS:

At 12 months, 26 of the 41 PVI with RD patients (63%) were AF-free vs 16 of the 39 patients (41%) in the PVI-only group (P = .014). In patients with severe hypertension, 11 of the 18 PVI with RD patients (61%) vs 5 of the 18 PVI-only patients (28%) were AF-free (P = .03). For moderate hypertension, the differences were less dramatic: 11 of 21 (52%) vs 15 of 23 (65%) when RD added (P = .19). The superior efficacy of adding RD was most apparent in persistent AF and severe hypertension (hazard ratio 0.25, confidence interval 0.09-0.72, P = .01). Duration of the procedure and fluoroscopy were nonsignificantly longer in the RD group.

CONCLUSION:

RD may improve the results of PVI in patients with persistent AF and/or severe resistant hypertension.

TRIAL REGISTRATION:

ClinicalTrials.gov NCT01117025 NCT01897545.

KEYWORDS:

Ablation; Atrial fibrillation; Renal denervation; Resistant hypertension

PMID:
24691452
DOI:
10.1016/j.hrthm.2014.03.055
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center